Connecting you to content on EBSCOhost

Works by Muller, Mirte

Results: 5

1

Prognostic Value of Deep Learning-Mediated Treatment Monitoring in Lung Cancer Patients Receiving Immunotherapy.

Published in:

Frontiers in Oncology, 2021, p. N.PAG, doi. 10.3389/fonc.2021.609054

By:

Trebeschi, Stefano;
Bodalal, Zuhir;
Boellaard, Thierry N.;
Tareco Bucho, Teresa M.;
Drago, Silvia G.;
Kurilova, Ieva;
Calin-Vainak, Adriana M.;
Delli Pizzi, Andrea;
Muller, Mirte;
Hummelink, Karlijn;
Hartemink, Koen J.;
Nguyen-Kim, Thi Dan Linh;
Smit, Egbert F.;
Aerts, Hugo J. W. L.;
Beets-Tan, Regina G. H.

Publication type:

Article

2

Head-to-head comparison of composite and individual biomarkers to predict clinical benefit to PD-1 blockade in non-small cell lung cancer.

Published in:

PLoS ONE, 2024, v. 19, n. 7, p. 1, doi. 10.1371/journal.pone.0293707

By:

Hummelink, Karlijn;
van der Noort, Vincent;
Muller, Mirte;
Schouten, Robert D.;
van den Heuvel, Michel M.;
Thommen, Daniela S.;
Smit, Egbert F.;
Meijer, Gerrit A.;
Monkhorst, Kim

Publication type:

Article

3

Modeling Diagnostic Strategies to Manage Toxic Adverse Events following Cancer Immunotherapy.

Published in:

Medical Decision Making, 2021, v. 41, n. 6, p. 693, doi. 10.1177/0272989X211002756

By:

van Delft, Frederik;
Muller, Mirte;
Langerak, Rom;
Koffijberg, Hendrik;
Retèl, Valesca;
van den Broek, Daan;
IJzerman, Maarten

Publication type:

Article

4

New targeted treatments for non-small-cell lung cancer -- role of nivolumab.

Published in:

Biologics: Targets & Therapy, 2016, v. 10, p. 103, doi. 10.2147/BTT.S87878

By:

Giulia Zago;
Muller, Mirte;
van den Heuvel, Michel;
Baas, Paul

Publication type:

Article

5

Pembrolizumab for the treatment of non-small cell lung cancer.

Published in:

2017

By:

Muller, Mirte;
Schouten, Robert D.;
De Gooijer, Cornedine J.;
Baas, Paul

Publication type:

journal article